<?xml version='1.0' encoding='utf-8'?>
<record xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
			<header>
				<identifier>oai:aavptbiennial-ojs-tamu.tdl.org:article/3</identifier>
				<datestamp>2022-06-25T02:29:17Z</datestamp>
				<setSpec>aavptbiennial:S1</setSpec>
			</header>
			<metadata>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Towards the Delivery of Personalized Medicine in Veterinary Oncology</dc:title>
	<dc:creator xml:lang="en">Khanna, Chand</dc:creator>
	<dc:subject xml:lang="en">cancer</dc:subject>
	<dc:subject xml:lang="en">veterinary oncology</dc:subject>
	<dc:subject xml:lang="en">canid cancer</dc:subject>
	<dc:subject xml:lang="en">genetic model</dc:subject>
	<dc:subject xml:lang="en">precision medicine</dc:subject>
	<dc:description xml:lang="en">Cancer is a genetic disease that arises as a consequence of the stepwise accumulation of disruptive mutations in genes that regulate cell life and death. Clonal expansion of cell populations bearing cancer gene mutations fues the formation of malignant tumors. This genetic model of cancer emerged in the latter 20th century as a product of advances in genetics, evolution, and cancer medicine. Through this mutational process, cancers acquire specific key properties including self-sufficient growth signaling, resistance to growth inhibitory signaling, invasion and metastasis, unlimited replication potential, angiogenic signaling, immune modulation, DNA instability, metabolic dysregulation, and immune evasion. The genetic model and its downstream phenotypes have since been validated in many cancer types and provide a framework for our growing genomic understanding of cancer.</dc:description>
	<dc:publisher xml:lang="en">AAVPT Biennial Symposia</dc:publisher>
	<dc:date>2017-05-22</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://aavptbiennial-ojs-tamu.tdl.org/aavptbiennial/article/view/3</dc:identifier>
	<dc:source xml:lang="en">AAVPT Biennial Symposia; 20th Biennial Symposium; 8-11</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://aavptbiennial-ojs-tamu.tdl.org/aavptbiennial/article/view/3/2</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 2017 American Academy of Veterinary Pharmacology and Therapeutics</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		
